This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...